September 14, 2026

FDA broadens APDS treatment options

An 8-patient study evaluated safety and pharmacokinetics in the younger pediatric population.

MDSpire News

August 17, 2026

Can nasal polyps affect mental health?

Asthma and higher Sinonasal Outcome Test-22 scores were associated with possible anxiety among adults undergoing endoscopic sinus surgery.

MDSpire News

August 10, 2026

FDA Approves Melanoma BRAF Companion Test

The assay is indicated to identify patients with advanced melanoma who have BRAF V600E or BRAF V600K variants and may benefit from FDA-approved targeted therapies.

MDSpire News

August 07, 2026

FDA Approves Viral Therapy Plus Nivolumab

Accelerated approval is based on objective response rate and duration of response in advanced melanoma, with postapproval trials required to confirm clinical benefit.

MDSpire News

August 04, 2026

Distribution Barriers May Reduce Biologic Drug Survival

A real‐world Brazilian registry suggests that challenges in biologic distribution were associated with treatment interruption, particularly among therapies requiring more frequent dosing.

MDSpire News